Ameritas Investment Partners’s Aldeyra Therapeutics ALDX Stock Holding History

Ameritas Investment Partners’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,846	Closed	-$6.5K	–	3180
2026 Q1	$6.5K	Hold	3,846	–	–	﹤0.01%	2946
2025 Q4	$19.9K	Hold	3,846	–	–	﹤0.01%	2645
2025 Q3	$20.1K	Hold	3,846	–	–	﹤0.01%	2661
2025 Q2	$14.7K	Hold	3,846	–	–	﹤0.01%	2809
2025 Q1	$22.1K	Hold	3,846	–	–	﹤0.01%	2507
2024 Q4	$19.2K	Hold	3,846	–	–	﹤0.01%	2650
2024 Q3	$20.7K	Hold	3,846	–	–	﹤0.01%	2639
2024 Q2	$12.7K	Hold	3,846	–	–	﹤0.01%	2831
2024 Q1	$12.6K	Hold	3,846	–	–	﹤0.01%	2753
2023 Q4	$13.5K	Hold	3,846	–	–	﹤0.01%	2743
2023 Q3	$25.7K	Hold	3,846	–	–	﹤0.01%	2426
2023 Q2	$32.3K	Buy	+3,846	New	+$37.9K	﹤0.01%	2296
2022 Q2	–	Sell	-3,805	Closed	-$17K	–	3060
2022 Q1	$17K	Hold	3,805	–	–	﹤0.01%	2614
2021 Q4	$15K	Hold	3,805	–	–	﹤0.01%	2755
2021 Q3	$33K	Hold	3,805	–	–	﹤0.01%	2406
2021 Q2	$43K	Buy	+3,805	New	+$45.8K	﹤0.01%	2283
2020 Q2	–	Sell	-1,388	Closed	-$3K	–	3064
2020 Q1	$3K	Hold	1,388	–	–	﹤0.01%	2900
2019 Q4	$8K	Hold	1,388	–	–	﹤0.01%	2794
2019 Q3	$7K	Hold	1,388	–	–	﹤0.01%	2838
2019 Q2	$8K	Hold	1,388	–	–	﹤0.01%	2853
2019 Q1	$13K	Hold	1,388	–	–	﹤0.01%	2584
2018 Q4	$12K	Hold	1,388	–	–	﹤0.01%	2582
2018 Q3	$19K	Hold	1,388	–	–	﹤0.01%	2528
2018 Q2	$11K	Buy	+1,388	New	+$11.1K	﹤0.01%	2802

Other funds holding ALDX

KCM

Knoll Capital Management Miami, Florida $214M AUM 62.74% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Ameritas Investment Partners's ALDX Position: Q2 2026 in Review

Ameritas Investment Partners sold out of Aldeyra Therapeutics (ALDX) in Q2 2026, closing a stake of 3,846 shares — an estimated $6.5K sold.

Ameritas Investment Partners first reported a position in ALDX in Q2 2018 and held it in 24 quarters. The position peaked at $43K in Q2 2021. 107 funds tracked by Wall St. Rank hold ALDX as of Q2 2026.

Ameritas Investment Partners reported no remaining Aldeyra Therapeutics position as of Q2 2026 after selling out during the quarter.
Ameritas Investment Partners sold 3,846 Aldeyra Therapeutics shares in Q2 2026, an estimated $6.5K.
Ameritas Investment Partners first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 24 quarters.
Ameritas Investment Partners's Aldeyra Therapeutics position peaked at $43K in Q2 2021.
107 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.